[{"NetIncomeLoss_1_Q1_USD":-18460000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":12764000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_1_Q1_USD":100000.0,"InterestPaidNet_1_Q1_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-21000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":48400000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":10872000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":6336347.0,"AssetsCurrent_0_Q1_USD":121534000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":27251218.0,"CommonStockSharesIssued_0_Q1_shares":7231370.0,"Assets_0_Q1_USD":122832000.0,"UnrealizedGainLossOnInvestments_1_Q1_USD":-13000.0,"ShareBasedCompensation_1_Q1_USD":3175000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":372000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"RepaymentsOfNotesPayable_1_Q1_USD":0.0,"OtherNoncashIncomeExpense_1_Q1_USD":5000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":6160000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"Liabilities_0_Q1_USD":16834000.0,"ClassOfWarrantOrRightOutstanding_0_Q1_shares":441545.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":400000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":3160000.0,"CommonStockValue_0_Q1_USD":72000.0,"IncomeTaxExaminationPenaltiesAndInterestExpense_1_Q1_USD":0.0,"DepreciationDepletionAndAmortization_1_Q1_USD":33000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":13806000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":1259000.0,"RealizedInvestmentGainsLosses_1_Q1_USD":4000.0,"InterestAndDebtExpense_1_Q1_USD":0.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":0.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":67539000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":117100000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-18460000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_1_Q1_USD":-13000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-18473000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":2715000.0,"OtherAssetsNoncurrent_0_Q1_USD":1000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":33000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"ShortTermInvestments_0_Q1_USD":70611000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":3622000.0,"ImpairmentOfLongLivedAssetsHeldForUse_1_Q1_USD":0.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":56652000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_1_Q1_USD":0.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":1765000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q1_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":3175000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-11539000.0,"LiabilitiesCurrent_0_Q1_USD":16436000.0,"AccountsPayableCurrent_0_Q1_USD":3384000.0,"CommonStockSharesOutstanding_0_Q1_shares":7231370.0,"NonoperatingIncomeExpense_1_Q1_USD":55000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":3052000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":330000.0,"AdditionalPaidInCapital_0_Q1_USD":242304000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q1_USD":15.94,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":12000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":148000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":46489000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":592000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-297347000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":3153624.0,"OperatingIncomeLoss_1_Q1_USD":-18515000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q1_shares":2431561.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":288000.0,"PreferredStockValue_0_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":122832000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":2721000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":3175000.0,"ProceedsFromIssuanceOfWarrants_1_Q1_USD":1259000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":1913000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":355000.0,"OperatingExpenses_1_Q1_USD":19966000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-2.91,"OtherLiabilitiesNoncurrent_0_Q1_USD":33000.0,"StockholdersEquity_0_Q1_USD":105998000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":15000.0,"AccretionExpense_1_Q1_USD":0.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-232000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":1451000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":252000.0,"Ticker":"VRDN","CIK":"1590750","name":"VIRIDIAN THERAPEUTICS, INC.DE","OfficialName":"Viridian Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"445189274.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210507"}]